COMPANY PROFILE

Protedyne Corporation

Explore full profile

Provide support for all of its existing pharmaceutical, biotech and diagnostic testing customers

Bloomfield, United StatesFounded 2000Biotech & Life Sciences

Valuation $50–100M Last recorded · 2001

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Protedyne Corporation

Protedyne, a subsidiary of LabCorp, specializes in laboratory automation systems designed to enhance productivity and ensure accurate diagnostic outcomes. The company operates in the healthcare and diagnostics market, serving clinical laboratories and research institutions. Protedyne's business model revolves around the development and deployment of advanced automation technologies that streamline laboratory workflows, thereby eliminating repetitive tasks and allowing lab personnel to focus on more critical activities. Revenue is generated through the sale of automation systems, maintenance services, and remote diagnostic support. The company prides itself on improving employee welfare and the security of patient samples through its innovative solutions. Protedyne's commitment to customer satisfaction is evident in its ability to remotely diagnose and fix most issues, minimizing downtime and ensuring continuous operation of its systems.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2000
Headquarters: Bloomfield, United States
Open positions: None listed
Dealroom signal: 22.3/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Testing, Biotechnology, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
Technology: Hardware
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Oct 2001	$12M	$48M	Sprout Group · LRVHealth · Meridian Venture Partners · Boston Community Venture Fund	—

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Protedyne Corporation website traffic

Latest recorded traffic for Protedyne Corporation is 1.5K monthly website visits, up 248.8% over the last three months.

Latest monthly visits1.5K 3-month web change+248.8%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
LALabConnectLabConnect enhances lives by collaborating with pharma/biotech firms and CROs to speed up global medicine development	Johnson City, United States	Operational	598	$29M	—
PGProbably GeneticProbably Genetic helps rare genetic disease patients get diagnosed	San Francisco, United States	Operational
BIBeijing Saifu Pharmaceutical Research InstitutePreclinical CRO service provider dedicated to the toxicological testing and safety evaluation of drugs	Dongcheng District, China	Operational
GEGentrisGlobal provider of pharmacogenomic testing and biorepository services	Morrisville, United States	Acquired
BIBioTheranosticsExtensive research generates high-complexity molecular tools that help physicians execute more informed treatment decisions	San Diego, United States	Acquired
PRProterixBioDeveloping innovative products to transform the management of chronic diseases	Billerica, United States	Closed
SCStablecoin Development CorporationPublicly traded on-chain vehicle for the stablecoin economy, formerly NovaBay Pharmaceuticals	Emeryville, United States	Acquired
LBLandos BiopharmaA clinical stage biopharmaceutical company focused on the development of first-in-class therapeutics for patients with autoimmune disease	Ashtabula, United States	Acquired